Gastro Medical News about esophageal adenocarcinoma

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation
Anti-Cancer Drugs, 07/01/09

Woodall CE et al. - Morphological characteristics consistent with decreased esophagitis and incidences of metaplasia and esophageal adenocarcinoma were seen on histopathology in the resveratrol group. Resveratrol resulted in a small diminution of the carcinogenic effects and progression to metaplasia, and further human studies are designed to explore the potential anticarcinogenic mechanism.

<< Previous
Trends in body mass index and waist circumference among New...

Next >>
The galactose elimination capacity and mortality in 781 Danish...

MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival
Clinical Cancer Research, 10/01/09 Relevance Score: 67%

Increased risk of oesophageal adenocarcinoma among upstream petroleum workers
Occupational and Environmental Medicine, 11/06/09 Relevance Score: 66%

Preoperative and Early Postoperative Quality of Life Predict Survival in Potentially Curable Patients with Esophageal Cancer
Annals of Surgical Oncology, 10/20/09 Relevance Score: 66%

Sweets syndrome with neurologic manifestations in a patient with esophageal adenocarcinoma: case report and review of the literature
International Journal of Dermatology, 10/01/09 Relevance Score: 65%

Role of a novel bile acid receptor TGR5 in the development of esophageal adenocarcinoma
Gut, 11/23/09 Relevance Score: 64%